EnviroTechnologies International Inc. (ETII)

[punk153]

HNSS DD (wcrash655)

Sunday, November 14, 2010 10:36:26 AM
Post 11258

Massive DD w/ Links and Charts


About Healthnostics:
Healthnostics, Inc. is a medical product manufacturer, system manufacturer and product distributor company. Healthnostics' subsidiary, Worldwide Wipes Co., is a manufacturer and distributor of medical and general swabs.
For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com.



Important Series of PR's Giving View of Healthnostics NEW Company Direction and Important Developments:


June 29th, 2010 PR:

Healthnostics Initiates Investment in Medical Manufacturing Company
Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has initiated its acquisition strategy with cash investments in a medical manufacturing company.

The Company will continue to provide additional details as its acquisition strategy continues to unfold.

"We have now moved from the planning stage to the implementation stage of our acquisition strategy, which means that the positive impact on our sales and earnings will come sooner than originally planned," said Alan Grofe, President.


June 30th, 2010 PR:

Healthnostics, Inc. Retires 90 Million Outstanding Shares
Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology
analytics company, announced that in addition to its recent investment in a medical manufacturing company, it has invested in the repurchase of 90 million shares of its common stock in a private transaction, thereby reducing the actual issued and outstanding shares to 305,857,509. Of this total, the approximately 39 million shares which are not closely held are traded in the public market. These shares constitute the public float.

Both the investment in an ongoing acquisition and the investment in the repurchase of shares will have the immediate effect of increasing shareholder equity through significantly enhanced earnings per share.


July 6th, 2010 PR:
Healthnostics Agrees to Acquire Medical Manufacturing Company
Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has agreed to acquire a medical manufacturing company on multi-year terms that include benchmarks of a first year profit target range of $300,000-$600,000 and a second year target range of $600,000-$900,000. These numbers do not include the benefits of reinvestment by the company in (a) manufacturing, (b) existing company products, and (c) reduction of outstanding shares through company purchases. As a result, the medical manufacturing profits can potentially have a multiplier effect on the Company's earnings per share.


July 13th, 2010 PR:

Healthnostics Completes Acquisition
Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has completed its acquisition of Worldwide Wipes Co., "a U.S. manufacturer and distributor of wipes for medical, veterinary, disinfecting, and a variety of other uses, and the company's market ranges from cartons for individuals to truckloads for corporations. The Company places a priority on price, quality, and convenience, providing prompt, free shipping."

Terms of the acquisition include net profit benchmarks of $300,000 to $600,000 in the first year and $600,000 to $900,000 in the second year.

"We are pleased to announce the completion of the most important event in our Company's history. The Worldwide Wipes price points are exceptionally competitive, and its customer base is nationwide. Following several years of base-building, this acquisition represents such a quantum leap for Healthnostics that we are contemplating a name and stock symbol change that reflects the diversified nature and direction of the Company," said President Alan Grofe.


July 15th, 2010 PR

Healthnostics Repurchases 150 Million Shares of Its Stock
Healthnostics, Inc. (PINKSHEETS: HNSS), a medical manufacturing and biotechnology analytics company, has sold an interest in MedBioWeb, Corp., in exchange for 150 million shares of its common stock, thereby reducing the actual issued and outstanding shares of Healthnostics, Inc., to 155,857,509.

As the Company refocuses its business, it is contemplating the possibility of a sale of its remaining interest in MedBioWeb Corp. MedBioWeb Corp. may more readily achieve its profit goals as an independent company and Healthnostics, through its recent acquisition, may be more able to show a substantial increase in per share earnings due to the near halving of outstanding shares.

The Company will continue to pursue acquisitions that are both compatible and synergistic.

"The Company is witnessing dramatic changes, all of which we believe bode well for our stockholders. We are focusing on profitability and earnings per share, factors that will enhance our ability to thrive and grow," said Alan Grofe, president.


October 10th, 2010 PR:

Healthnostics Purchases Major Manufacturer of Specialty Medical Products
Healthnostics, Inc., (PINKSHEETS: HNSS), a medical manufacturing and biotechnology analytics company, has purchased a major manufacturer of specialty medical products. There will be an immediate positive impact on revenue and earnings commencing in the 1st Quarter of 2011. Details will be forthcoming in subsequent press releases.

"This accretive purchase directly ties into the Company's recent acquisition of World Wide Wipes Co., and it will result in even more substantial impact on our profitability and earnings per share," said Alan Grofe, president.



October 20th, 2010 PR:

Healthnostics Announces MicroFill-2160
Healthnostics, Inc., (PINKSHEETS: HNSS), announced the development of its new fill-and-seal machine, MicroFill-2160, through its specialty medical products manufacturing division. MicroFill-2160 is being designed to produce 2,160 medical pads per minute, which is nearly three times faster than other similar machines in use today. Further, MicroFill-2160 will be built with a footprint substantially smaller than other machines, which means it will take up less clean-room space, and be manageable by fewer operators. These speed, space, and labor benefits will significantly reduce manufacturing costs, and this breakthrough machine will make possible the company's soon-to-be-announced unique manufacturing and distribution concept. The company will seek a patent for MicroFill-2160.


October 26th, 2010 PR:

Healthnostics Announces MobileCleanRoom
Healthnostics, Inc. (PINKSHEETS: HNSS) announced the development of MobileCleanRoom. Medical manufacturing requires the use of FDA-mandated clean rooms that meet specific standards of ventilation, clean air and clean surfaces, and contamination and environmental controls. MobileCleanRoom will be a Class 100 clean room containing no more than 100 particles 0.5 micron diameter or larger per cubic foot of air.

Unlike modular or portable clean rooms, MobileCleanRoom is being designed as a complete manufacturing site on wheels specifically for MicroFill-2160, the Company's recently announced small footprint, high production machine.

Benefits include:

* Low-cost, low-overhead manufacturing facility;
* Onboard water purification system;
* Rapid deployment to prime market locations;
* Rapid business expansion;
* Reduced utility usage;
* Separate units for separate products.

MobileCleanRoom represents another advance in the Company's drive toward profitability through reduced-footprint technology.


October 29th, 2010 PR:

Healthnostics Doubles Online Sales
Healthnostics, Inc. (PINKSHEETS: HNSS) announced that monthly online sales through its Worldwide Wipes Co. subsidiary have increased by more than 200 percent since it was acquired in July, and this trend is continuing.

Both the number of units sold and the price per unit increased while overhead decreased as strides were made in the reduction of shipping, packaging, and advertising costs.

The Company plans to capitalize on this success through the expansion of product lines and marketing outlets.

Worldwide Wipes Co. is a U.S. manufacturer and distributor of wipes for medical, veterinary, disinfecting, and a variety of other uses, and the company's market ranges from cartons for individuals to truckloads for corporations
. The Company places a priority on price, quality, and convenience, providing prompt, free shipping.


November 2nd, 2010 PR:

Healthnostics Announces Stock Repurchase Plan
Healthnostics, Inc. (PINKSHEETS: HNSS) is seeking blocks of Healthnostics stock of at least 500,000 or more free-trading shares. Stockholders wishing to sell their stock should contact the company by November 12, 2010, at [e-mail] and state the quantity, desired price, and contact information. The stock must be in certificate form. The Company will not charge or receive compensation in any form.


November 8th, 2010 PR:

Healthnostics Sells MedBioWeb Corp. for $2 Million
Healthnostics, Inc. (PINKSHEETS: HNSS) announced the sale of its subsidiary, MedBioWeb Corp., to a consortium of investors for cash and publicly-traded securities
valued at $2 million.

Healthnostics president, Alan Grofe, who will continue on with MedBioWeb Corp., is being succeeded at Healthnostics on an interim basis by Michael Black, the Company's current chief financial officer.

The sale of MedBioWeb Corp. includes MedGuardian, a patient care monitoring and risk management system for hospitals, MedBioWorld.com, a professional medical and biotechnology directory, and FamilyMedicalNet.com, a consumer healthcare information portal.

This sale facilitates the Company's transition from on-line medical information to the lucrative businesses of on-line medical product distribution, conventional distribution, medical product manufacturing and the engineering and development of manufacturing machines and systems.


Michael Black, the new CEO, Major Capital Infusion to Healthnostics in 2008

March 24th, 2008 PR:

Healthnostics Eliminates $800,000 Debt
BETHESDA, Md.--(BUSINESS WIRE)--Healthnostics, Inc. (OTC:HNSO), a medical and biotechnology analytics information and technology company, announced it is increasing shareholders’ equity by eliminating all long-term debt. An infusion of $250,000 from Chairman and CFO Michael Black in exchange for 25 million shares of HNSO stock that is subject to Rule 144 which Mr. Black purchased at a premium to market, settled the $800,000 debt.

The transaction increased stockholder equity due to the investment and from the $550,000 gain on the transaction. Mr. Black purchased the shares at more than twice the current market price.

“This transaction reaffirms management’s strong conviction in meeting the Company’s short and long term objectives and our belief that the Company’s stock is presently undervalued. This represents a critical milestone in the Company’s path toward profitability,” said President Alan W. Grofe.



A Few Of The Key Points To Be Taken From These PR's:
1) Healthnostics is progressively transitioning itself into a the Medical Manufacturing Industry which is a Multi-Billion Dollar industry.
2) They have kept shareholders informed of every new development as it happens.
3) All PR's have been worded in very important ways, not to give too much information at once.
4) Instead of diluting because they know the have something great in the making, the company has bought and/or canceled shares of the stock on two separate occasions down to 155M shares outstanding already, with another share buyback in the works.
5) On multiple occasions the company has put hard emphasis on increasing shareholder value and earnings per share with this new direction; their efforts are becoming more and more apparent.
6) They have already engineered a new and innovative piece of medical manufacturing equipment in the MicroFill-2160 which are waiting to here more about as well as the MobileCleanRoom.
7) They have already increased sales from Worldwide Wipes Co. by over 200% since its acquisition in July 2010.
8) The new CEO of Healthnostics will be Michael Black the current CFO and the person who it seems has been the mastermind behind orchestrating this entire new and lucrative company direction from the beginning.
9) Last but certainly not least, so far the company has followed through with every single thing they have promised during the progression of this transition and kept the interest of shareholders in the forefront.